Trump administration: Drugmakers that hiked prices may create ‘tipping point’

HHS Secretary Alex Azar was speaking Monday at the summer conference for the 340B Coalition, which represents programs and providers that support the drug discount program. It came as President Trump threatened action against companies like Pfizer for raising drug prices.

Read the full post on FierceHealthcare: Payer